Related by context. Frequent words. (Click for all words.) 73 safety tolerability pharmacokinetics 71 pharmacokinetics PK 69 pharmacodynamic effects 67 label dose escalation 67 efficacy tolerability 67 analgesic efficacy 67 safety tolerability 67 SCH # 67 pharmacodynamics 66 pharmacokinetic PK 66 Azedra 66 Phase Ib clinical 65 elotuzumab 65 nab paclitaxel 65 pharmacokinetics 65 liposomal formulation 64 active comparator 64 placebo controlled clinical 64 pertuzumab 64 CR# vcMMAE 64 PXD# 64 vorinostat 64 Traficet EN 63 tanespimycin 63 tolerated dose MTD 63 Carfilzomib 63 IMC A# 63 biodistribution 63 BrachySil 63 Randomized controlled 62 pharmacodynamic 62 tolerability 62 DAVANAT 62 HER2 positive metastatic breast 62 double blinded placebo 62 HGS ETR1 62 PREZISTA r 62 KRN# 62 MORAb 62 pharmacokinetic profiles 62 romidepsin 62 relapsing multiple sclerosis 62 ascending doses 62 nonrandomized 62 Solid Tumors 61 Natalizumab 61 Clinical Trial Results 61 Imprime PGG 61 docetaxel chemotherapy 61 imetelstat 61 Pivotal Phase III 61 rNAPc2 61 Amrubicin 61 OncoVEX GM CSF 61 ALN TTR# 61 Pegasys ® 61 Sym# 61 genotoxicity 61 PEG SN# 61 placebo controlled Phase 61 Pivotal Phase 61 Tolerability 61 xenograft models 61 Secondary endpoints 61 Phase Ib 61 phase IIb clinical 61 Pharmacokinetic 60 dosing regimens 60 placebo controlled randomized 60 orally bioavailable 60 optimal dosing 60 BAY #-# 60 dose limiting toxicities 60 Vandetanib 60 phase IIb 60 Phase 1b trial 60 thymalfasin 60 talabostat 60 prospective randomized controlled 60 dose escalation trial 60 Panzem R 60 axitinib 60 efficacy 60 anti fibrotic 60 myeloproliferative disorders 60 plus prednisone 60 adecatumumab 60 prospectively defined 60 intravesical 60 patients undergoing percutaneous 59 daunorubicin 59 Bioavailability 59 secondary efficacy endpoints 59 Immunogenicity 59 primary hypercholesterolemia 59 ganetespib 59 EFAPROXYN 59 relapsed refractory multiple myeloma 59 OBJECTIVES 59 label multicenter 59 antitumor activity